Innovative study designs and comprehensive regulatory expertise for medical device and drug-device combination trials.
In the realm of clinical research, medical devices constitute a diverse and critical category. At Genelife Clinical Research, we bring extensive experience and unwavering commitment to excellence in conducting medical device and drug-device combination clinical trials — positioning us as a trusted medical device CRO in India.
In medical device trials, we structure the study hypothesis to specifically test particular outcomes. This tailored approach ensures relevance and effectiveness of the study design for each unique device.
We proactively include predetermined population subsets in study designs — enhancing the study's applicability, statistical power, and real-world relevance of results.
Flexible study designs that allow protocol modifications based on interim data — improving efficiency and the likelihood of successful outcomes for medical device trials.
Systematic PMCF studies to evaluate long-term safety and performance of approved medical devices — meeting ongoing regulatory requirements.
Medical Device Rules 2017, clinical investigation approvals, investigator site permissions, and product registration under Indian regulations.
Investigational Device Exemptions (IDE), 510(k) premarket notifications, PMA applications, and De Novo classification requests.
Medical Device Regulation (EU) 2017/745 compliance, CE Mark pathway support, notified body interactions, and EUDAMED submissions.
Integration of ISO 13485, 21 CFR 820, CMDCAS, and MDD requirements into scalable quality management systems for global market access.
Genelife Clinical Research recognizes the intricacies of medical device trials and has positioned itself as a trusted partner for those seeking to navigate this complex terrain — combining innovation, ethical conduct, and regulatory excellence as a specialist medical device CRO in India.